
Xovir200 mg/5 m
Beacon Pharmaceuticals PLC
Genital Herpes (Oral Acyclovir) Acyclovir is an FDA-approved, guideline-supported (CDC) treatment for genital herpes caused by herpes simplex virus.
Acyclovir is an FDA-approved, guideline-supported (CDC) treatment for genital herpes caused by herpes simplex virus. It is indicated for:
Acyclovir is an established, FDA-approved treatment for acute herpes zoster (shingles) in immunocompetent adults, most effective when started within 72 hours of rash onset.
Acyclovir is FDA-approved for treatment of chickenpox in patients 2 years and older. However, current CDC/AAP guidance does not recommend routine Acyclovir treatment for otherwise healthy children with typical, uncomplicated chickenpox; oral Acyclovir is guideline-supported specifically for higher-risk groups — healthy individuals older than 12 years, those with chronic skin or lung disease, patients on long-term salicylate or corticosteroid therapy, and secondary household cases — when Acyclovir is started within 24 hours of rash onset.
Acyclovir cream 5% is FDA-approved for treatment of recurrent herpes labialis (cold sores) on the lips and face in immunocompetent adults and adolescents 12 years and older, applied during the prodrome or as soon as lesions appear. Use of Acyclovir cream in immunocompromised patients has not been established.
Intravenous Acyclovir is an established, guideline-supported treatment for infections that are severe, disseminated, or occurring in patients who cannot tolerate oral therapy, including:
IV Acyclovir must be administered by, or under the direction of, a qualified healthcare professional in a hospital setting.
Acyclovir dosing is not one-size-fits-all — the strength, frequency, formulation (tablet, suspension, cream, or IV infusion), and duration of Acyclovir treatment all depend on the specific infection being treated, the patient's age, weight, kidney function, and immune status. The table below is a general reference; the exact dose and course of Acyclovir must always be determined and prescribed by a qualified healthcare professional.
Acyclovir can commonly cause nausea, vomiting, diarrhea, headache, and tiredness/malaise with oral or IV use, and mild rash or itching. With Acyclovir cream, local skin reactions such as dryness, burning, stinging, cracking, or flaking at the application site may occur. With IV Acyclovir, pain or inflammation at the infusion site is common.
Acyclovir is contraindicated in patients with known hypersensitivity to Acyclovir or to valacyclovir (which is converted to Acyclovir in the body).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.